Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Temozolomide for the Treatment of Mycosis Fungoides and the Sezary Syndrome

NCT00004106 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT00004106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Temozolomide for the Treatment of Mycosis Fungoides and the Sezary Syndrome
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
May 31, 1998
Completion date
April 30, 2006
Enrollment
29 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma